A Stanford-led team has replaced toxic pre-transplant chemotherapy with a targeted antibody, allowing children with Fanconi ...
Key opportunities in the U.S. regenerative medicine market include the rising adoption of stem cell technology and a strong ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback